Physician profile
Amy Thompson
NPI 1841985694
$1,402.11
in general payments reported to CMS, 2019-2025
10 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $311 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,402.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $605.47 | 2025 | Pangea, Gmrs, Aequalis Perform Reversed |
| Vericel Corporation | $248.71 | 2024-2025 | Maci |
| Solventum Corporation | $160.80 | 2024-2025 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Bioventus LLC | $110.08 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Axogen | $87.26 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $67.31 | 2025 | |
| Smith+Nephew, INC. | $47.28 | 2024-2025 | Evos, Collagenase Santyl |
| Rattan and Associates | $33.46 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.60 | 2025 | Exparel |
| Convatec INC. | $20.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.